St. Jude Medical founder Manny Villafaña’s newest medical play, Medical 21, has registered for an upcoming $10 million equity offering, according to a recently posted SEC filing. The company, which was unveiled in late 2017, is developing an artificial blood vessel as an alternative to harvesting blood vessels for coronary artery bypass surgeries, and has […]
medical21
Villafaña-founded artificial vessel developer Medical 21 looks to raise $15m
St. Jude Medical founder Manny Villafaña’s newest medtech play, Medical 21, is looking to raise $15 million in an equity round of funding, according to an SEC filing posted recently. The company is developing an artificial blood vessel as an alternative to harvesting blood vessels for coronary artery bypass surgeries, and has already begun animal […]